pharma · Active Ulcerative Colitis
Tillotts Pharma AG
Tillotts Pharma AG is a pharma organization headquartered in CN. Primary therapeutic focus areas include Active Ulcerative Colitis. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to
rheinfelden, DE HQ
293 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- rheinfelden, DE
- Employees
- 293
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Asacol®
Phase 3 · small molecule · Active Ulcerative Colitis
Asacol® for Active Ulcerative Colitis is a Phase 3 program (small_molecule) at Tillotts Pharma AG with 1 ClinicalTrials.gov record(s).
Internal code 03010301A
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Tillotts Pharma AG
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Active Ulcerative Colitis
- Status
- completed
- Trials
- 1